Article
Molecular Updates in Prostate Cancer.
Surgical pathology clinics - 1 Dec 2015
Netto George J
Abstract excerpt
A wide array of molecular markers and genomic signatures, reviewed in this article, may soon be used as adjuncts to currently established screening strategies, prognostic parameters, and early detection markers. Markers of genetic susceptibility to PCA, recurrent epigenetic and genetic alterations, including ETS gene fusions, PTEN alterations, and urine-based early detection marker PCA3, are discussed. Impact of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
